Med-X

Med-X

Growth Stage

Making a Difference, Naturally.

Making a Difference, Naturally.

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

PicMii

Start Date

01/22/2023

Close Date

05/22/2023

Min. Goal
$10,000
Max. Goal
$3,000,000
Min. Investment

$500

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.25

Pre-Money Valuation

$43,211,544

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

05/22/2023

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Logos provided by Clearbit
Year Founded

2014

Industry

Consumer Products, Goods & Services

Tech Sector

Cleantech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Location

Canoga Park, California

Business Type

Growth

Company Website

Med-X, with a valuation of $43.2 million, is raising funds on PicMii. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues of people. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Med-X has a high demand and is known for its all-natural solutions and reported 80% revenue growth in 2022. Dr. David Toomey and Matthew Mills founded Med-X in February 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $3 million. The campaign proceeds will be used for acquisitions, marketing, working capital, hiring, product registrations, and research and development.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$1,010,431

$1,033,750

COGS

$879,662

$870,539

Tax

$1,600

$1,600

 

 

Net Income

$-4,907,432

$-3,541,031

Summary Balance Sheet

FY 2021 FY 2020

Cash

$1,367,366

$752,823

Accounts Receivable

$28,616

$150,929

Total Assets

$3,816,184

$3,166,753

Short-Term Debt

$30,927

$398,263

Long-Term Debt

$29,032

$11,438

Total Liabilities

$59,959

$409,701
Financials as of: 01/22/2023
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 11/08/2023 Dalmore Group $102,217,405 $3,936,422 Equity - Common Funded RegA+
Med-X 05/22/2023 PicMii $43,211,544 $0 Equity - Common Not Funded RegCF
Med-X 09/09/2021 truCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/26/2019 StartEngine - $7,000,471 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Med-X on PicMii 2023
Platform: PicMii
Security Type: Equity - Common
Valuation: $43,211,544
Price per Share: $0.25

Follow company

Follow Med-X on PicMii 2023
View on PicMii (Closed)
Deal Analytics
Company Ratings

Buy Med-X's Deal Report

Warning: according to the close date for this deal, Med-X may no longer be accepting investments.

Med-X Deal Report

Get KingsCrowd’s comprehensive report on Med-X including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Med-X is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Med-X deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge